Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1986-06-04
1988-05-03
Daus, Donald G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514292, 544361, 546 81, A61K 31495, A61K 31435, C07D40114, C07D48704
Patent
active
047420618
ABSTRACT:
There are disclosed novel compounds of the formula ##STR1## where m is 1 or 2; each X is independently H, halogen, loweralkyl, loweralkoxy, --CF.sub.3, or --OH; R is H, loweralkyl, chloroloweralkyl, bromoloweralkyl, iodoloweralkyl, aminoloweralkyl, loweralkylaminoloweralkyl, diloweralkylaminoloweralkyl, arylloweralkyl, diarylloweralkyl, thienylloweralkyl, furylloweralkyl, loweralkanoyl, chloroloweralkanoyl, bromoloweralkanoyl, iodoloweralkanoyl, aminoloweralkanoyl, loweralkylaminoloweralkanoyl, diloweralkylaminoloweralkanoyl, aroyl, arylloweralkanoyl or diarylloweralkanoyl, thienylloweralkanoyl, furylloweralkanoyl; and R.sub.1 is .dbd.O, ##STR2## or --NR.sub.2 R.sub.3, R.sub.2 and R.sub.3 being independently H or loweralkyl, or taken together with the nitrogen atom to which they are attached constituting ##STR3## R.sub.4 in turn being H, loweralkyl, hydroxyloweralkyl, aryl, arylloweralkyl or diarylloweralkyl, with the proviso that when R.sub.1 is --NR.sub.2 R.sub.3, R is nonexistent, that when R.sub.1 is .dbd.O, R is not an acyl group and that when R.sub.1 is ##STR4## R is not chloroloweralkyl, bromoloweralkyl or iodoloweralkyl; or pharmaceutically acceptable acid addition salts thereof, which are useful for enhancing memory.
REFERENCES:
Bauer & Hewitson, J. Org. Chem. 27, 3982 (1962).
Thyagarjan, Mechanism of Molecular Migrations pp. 251-289 (1971).
Campaigne, Mathews, J. Heterocyclic Chem. 12, 391 (1975).
Kolocouris, Rigo, Chimika Chronika, New Series II, 309 (1982).
Rigo, Fossaet, de Ouilarg & Kolocouris, J. Heterocyclic Chem. 21, 1381 (1984).
Ferlux, CA 85-32835X.
Soman, Merck Index, 10th Edition, 8559.
Tabun, Merck Index, 10th Edition, 8904.
Peter Davies, Drug Development Research 5:69-76 (1985).
Summers et al., The New England Journal of Medicine vol. 315, No. 20, (1986) pp. 1241-1245.
Goodman and Gilman's The Pharmacological Basis of Therapeutics Sixth Edition (1980) Chapter 6, Anticholinesterase Agent.
Johns et al., Drug Development Research 5:77-96 (1985).
Schindler et al., Drug Development Research 4:567-576 (1984).
Bartus et al., Science vol. 209 (1980) pp. 301-303.
Coyle et al., Science 219, 1184-1190 (1983).
Davis et al., The New England Journal of Medicine vol. 315, No. 2 (1986) pp. 1286-1287.
Martin Lawrence L.
Scott Susan J.
Setescak Linda L.
Daus Donald G.
Hoechst-Roussel Pharmaceuticals Inc.
Ikeda Tatsuya
Shen Cecilia
LandOfFree
Benzoc[c]-1,5-naphthyridines and related compounds as memory enh does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Benzoc[c]-1,5-naphthyridines and related compounds as memory enh, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Benzoc[c]-1,5-naphthyridines and related compounds as memory enh will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1506428